DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

« Back to Dashboard

Clinical Trials for Insulatard Nph Human

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00346996	Insulin Analogues and Severe Hypoglycaemia	Completed	Novo Nordisk A/S	Phase 4	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996	Insulin Analogues and Severe Hypoglycaemia	Completed	Lise Tarnow	Phase 4	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	Novo Nordisk A/S	Phase 4	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	The Danish Diabetes Association	Phase 4	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	The Institute of Experimental Clinical Research, University of Aarhus	Phase 4	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.

Clinical Trial Conditions for Insulatard Nph Human

Condition Name

Condition Name for Insulatard Nph Human
Intervention	Trials
Diabetes	7
Diabetes Mellitus, Type 2	4
Type 1 Diabetes	2
Healthy	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Insulatard Nph Human
Intervention	Trials
Diabetes Mellitus	8
Diabetes Mellitus, Type 2	6
Diabetes Mellitus, Type 1	4
Weight Gain	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Insulatard Nph Human

Trials by Country

Trials by Country for Insulatard Nph Human
Location	Trials
Denmark	3
Germany	2
Romania	1
Austria	1
Hungary	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Insulatard Nph Human

Clinical Trial Phase

Clinical Trial Phase for Insulatard Nph Human
Clinical Trial Phase	Trials
Phase 4	5
Phase 2	1
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Insulatard Nph Human
Clinical Trial Phase	Trials
Completed	10
Unknown status	2
Active, not recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Insulatard Nph Human

Sponsor Name

Sponsor Name for Insulatard Nph Human
Sponsor	Trials
Novo Nordisk A/S	8
University of Aarhus	1
Yaounde Central Hospital	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Insulatard Nph Human
Sponsor	Trials
Other	10
Industry	8

Export unavailable in trial.
Subscribe for complete access.